GHK-Cu for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

GHK-Cu for Health & Longevity

Created on 07/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A natural copper-carrying molecule the body uses to repair skin, declining with age. The strongest human evidence is for skin: softening wrinkles and improving firmness, though some benefit may come from copper itself. Claims for hair, brain, and whole-body aging rest on lab and animal work. Generally well tolerated on skin; unregulated injectable forms are riskier. (Full Review)

Protocol

Concentration
1–2% topical
Serum or cream; lower strength for sensitive skin
Frequency
Once–twice daily
Evening favored, on clean skin before heavier creams
Application
Split, repeated
Liposomal forms aid poor skin penetration
Time to effect
Wrinkles & photoaging
8–12 weeks
Gradual, with consistent daily use
Wound healing
Within days
Minor wounds, post-procedure skin
Firmness & elasticity
8–12 weeks
Cumulative over consistent use

Benefits

Contraindications
  • Wilson disease or copper-overload states
  • Known copper or metal allergy
  • Pregnancy or breastfeeding
  • Active skin infection, open wounds, or acute dermatitis at application site
  • Unregulated injectable products
    •
Key Interactions
  • Vitamin C serums (L-ascorbic acid)
  • Topical retinoids and exfoliating acids (retinol, tretinoin, glycolic or salicylic acid)
  • Copper chelators (alpha-lipoic acid, penicillamine, trientine)
  • High-dose oral zinc
  • Other copper sources and collagen-stimulating actives
    •

Risk & Side Effects

  • Medium: Skin irritation, redness, and contact dermatitis
    •
  • Low: Allergic sensitization to copper; adverse effects from unregulated injectable products
    •
  • Speculative: Systemic copper overload; pro-angiogenic effects and theoretical tumor risk
    •

Monitoring

Marker Target Why
Serum Copper 80–100 µg/dL Detects copper excess or deficiency with systemic use
Ceruloplasmin 20–35 mg/dL Main copper-carrying protein; screens for copper overload or Wilson disease
Serum Zinc 90–120 µg/dL Zinc and copper compete; added copper can shift the balance
Copper-to-Zinc Ratio ~0.7–1.0 An elevated ratio can signal copper excess or inflammation
hs-CRP <1.0 mg/L Tracks systemic inflammation, relevant to anti-inflammatory claims

Cadence: Systemic use: baseline, 8–12 weeks, then every 6–12 months. Topical users reassess skin at 8–12 weeks and periodically thereafter.

Qualitative Assessment

  • Visible skin firmness, elasticity, and reduced wrinkle depth in the treated area
  • Speed and quality of healing of minor wounds or post-procedure skin
  • Skin hydration, smoothness, and overall clarity
  • Tolerability — absence of persistent redness, stinging, or rash
  • For systemic users, general energy and well-being alongside stable copper labs
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.